Evaluation of WO2012037132 – a novel scaffold for selective JAK1 inhibition

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.9, 2012-09, pp. : 1105-1109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Highly selective Janus kinase 3 inhibitors based on a pyrrolo[2,3-d]pyrimidine scaffold: evaluation of WO2013085802

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 121-125

Informa Healthcare

Access to resources Recommend Favorite

Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1

By Winum Jean-Yves

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 757-760

Informa Healthcare

Access to resources Recommend Favorite

Selective JAK1 inhibitor and selective Tyk2 inhibitor patents

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1233-1249

Informa Healthcare

Access to resources Recommend Favorite

Boehringer Ingleheim's selective glucocorticoid receptor agonist development candidate: evaluation of WO2010141331, WO2010141332 and WO2010141333

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. : 1137-1142

Informa Healthcare

Access to resources Recommend Favorite

Scaffold evaluation of liguzinediol analogs as novel cardiotonic agents

By Liu Z. Li W. Qin K. Wen K. Zhu C. J. Li N. G. Bian H. M. Wen H. M. Chen L.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 12, 2013-12 ,pp. : 926-932

Govi-Verlag

Access to resources Recommend Favorite